The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus
Authors
Keywords
-
Journal
Viruses-Basel
Volume 12, Issue 2, Pages 173
Publisher
MDPI AG
Online
2020-02-05
DOI
10.3390/v12020173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Measles virus-based treatments trigger a pro-inflammatory cascade and a treatment-specific immunopeptidome in glioblastoma
- (2019) Srinath Rajaraman et al. Molecular Therapy-Oncolytics
- Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
- (2018) Pavlos Msaouel et al. CURRENT CANCER DRUG TARGETS
- Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
- (2018) Cheyne Kurokawa et al. JNCI-Journal of the National Cancer Institute
- Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo
- (2018) Jeannine Lacroix et al. Viruses-Basel
- Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
- (2018) Cheyne Kurokawa et al. JNCI-Journal of the National Cancer Institute
- The advent of oncolytic virotherapy in oncology: The Rigvir® story
- (2018) Pēteris Alberts et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Oncolytic Properties of a Mumps Virus Vaccine Strain in Human Melanoma Cell Lines
- (2018) Y. I. Ammour et al. MOLECULAR BIOLOGY
- The Role of Oncolytic Viruses in the Treatment of Melanoma
- (2018) Claire-Audrey Y. Bayan et al. Current Oncology Reports
- Oncolytic cancer therapy with a vaccinia virus strain
- (2018) Lili Deng et al. ONCOLOGY REPORTS
- Transcriptional Regulation of Antiviral Interferon-Stimulated Genes
- (2017) Wenshi Wang et al. TRENDS IN MICROBIOLOGY
- Autophagy in Measles Virus Infection
- (2017) Aurore Rozières et al. Viruses-Basel
- Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis
- (2017) Marina Emelyanova et al. Oncotarget
- Oncolytic Virus Immunotherapy for Melanoma
- (2015) Neal Dharmadhikari et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
- (2015) Carole Achard et al. Oncotarget
- Combination of vaccine-strain measles and mumps virus synergistically kills a wide range of human hematological cancer cells: Special focus on acute myeloid leukemia
- (2014) Li Feng Zhang et al. CANCER LETTERS
- Measles Vaccine Strains for Virotherapy of Non–Small-Cell Lung Carcinoma
- (2014) Manish R. Patel et al. Journal of Thoracic Oncology
- Measles Virus C Protein Impairs Production of Defective Copyback Double-Stranded Viral RNA and Activation of Protein Kinase R
- (2013) C. K. Pfaller et al. JOURNAL OF VIROLOGY
- Quantification of measles, mumps and rubella viruses using real-time quantitative TaqMan-based RT-PCR assay
- (2012) Y. Ammour et al. JOURNAL OF VIROLOGICAL METHODS
- Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma
- (2012) A. M. Murphy et al. JOURNAL OF VIROLOGY
- Measles virus causes immunogenic cell death in human melanoma
- (2011) O G Donnelly et al. GENE THERAPY
- Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma
- (2008) F Errington et al. GENE THERAPY
- Antiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulation
- (2008) A. Le Tortorec et al. HUMAN REPRODUCTION
- Cancer/testis genes expression in human melanoma cell lines
- (2008) Irina N. Mikhaylova et al. MELANOMA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started